| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |